Thursday July 16, 2020

Takeover bid for Elan unlikely to be accepted, says analyst

A takeover bid for Irish Dublin-headquartered pharma company Elan is unlikely to be accepted, according to one analyst.

26th February, 2013

A takeover bid for Irish Dublin-headquartered pharma company Elan is unlikely to be accepted, according to one analyst.

Jefferies analyst Corey Davis said today that the $11 a share offer from Royalty Pharma was unlikely to succeed given that Elan itself has a close to $4 billion dollar war chest for M&A activity itself.

Elan has already said that it plans to make acquisitions with the $3.25 billion it will receive from selling its stake...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 6 months ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 4 years ago